Phoebe Tsao
Clinical Assistant Professor of Internal Medicine, Medical School
Available to mentor
Phoebe Tsao
Clinical Assistant Professor
Manage Your Profile
Qualifications
-
Hematology/Oncology FellowshipUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2018 - 2021
Clinical Fellowship
-
Chief Medical ResidencyUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2017 - 2018
Chief Resident
-
Internal Medicine ResidencyUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2014 - 2017
Residency
-
MSc, Masters in Health and Healthcare ResearchUniversity of Michigan Medical School, Ann Arbor, United States
2021 - 2022
-
MDUniversity of Michigan Medical School, Ann Arbor, Michigan, United States
2010 - 2014
-
BAUniversity of Pennsylvania, Philadelphia, PA, United States
2005 - 2009
Center Memberships
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Center MemberEisenberg Family Depression Center
Recent Publications
-
Herrera Alzate G, Krischak M, Bank M, Lewicki P, Elliott D, Bryant A, Caram M, Tsao P, Radhakrishnan A, Dykstra M, Harrod M, Skolarus T, Sales A, Stensland K. 2026 Dec 16;Proceeding / Abstract / PosterAnalyzing Access and Availability of Genitourinary Cancer Clinical Trials for Veterans
-
Tsao P, Kumbier K, Visnic S, Sparks J, Alumkal J, Bohnert A, Caram M. 2026 Oct 2;Proceeding / Abstract / PosterImpact of androgen receptor pathway inhibitors on mental health in Veterans with metastatic androgen pathway modulation-naive prostate cancer
-
Strohbehn G, Mazur I, Azar I. 2026 Oct 25;PresentationSocial Determinants of Health Impacting Cancer Care
-
Tsao P, Urban-Wojcik E, Seewald M, Khan A, Bryant A, Palmbos PL, Smith DC, Tsung I, Vaishampayan U, Yentz SE, Alumkal J, Reichert Z, Caram MV. Journal of Clinical Oncology, 2026 Mar 2; 44 (7_suppl): 147 - 147.Proceeding / Abstract / PosterImpact of abiraterone versus enzalutamide on depression and anxiety in hormonesensitive prostate cancer (HSPC).
DOI:10.1200/JCO.2026.44.7_suppl.147 -
Miller SR, Chung DH, Gonzalez RT, Jackson WC, Caram MEV, Tsao PA, Stensland K, Gulati R, Shah Y, Wale D, Elliott D, Caverly T, Hofer TP, Saini S, Green MD, Schipper M, Dess RT, Bryant AK. Journal of Nuclear Medicine, 2025 Dec 1; 66 (12): 1891 - 1897.Journal ArticleImpact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer
DOI:10.2967/jnumed.125.270825 -
Tsao P, Kumbier K, Visnic S, Sparks J, Alumkal J, Bohnert A, Caram M. 2025 Oct 23;Proceeding / Abstract / PosterImpact of androgen receptor pathway inhibitors on mental health in Veterans with metastatic hormone-sensitive prostate cancer
-
Tang JD, Miller SR, Schipper M, Jackson WC, Stensland KD, Caram ME, Tsao PA, Elliott DA, Dess RT, Bryant AK. International Journal of Radiation Oncology*Biology*Physics, 2025 Sep 28; 123 (1): S216 - S216.Proceeding / Abstract / PosterIdentifying optimal candidates for PSMA PET staging of newly diagnosed intermediate risk prostate cancer: A report from the National Veterans Affairs System
DOI:10.1016/j.ijrobp.2025.07.1324 -
Philibert AL, Szymanski BR, Tsao PA, Bradford DW, Bowersox NW. General Hospital Psychiatry, 2025 Jul 1; 95: 44 - 51.Journal ArticleFive-year survival following a non-small-cell lung cancer diagnosis among Veterans Health Administration patients with schizophrenia and bipolar disorder
DOI:10.1016/j.genhosppsych.2025.04.004 PMID: 40273476